08:10-08:30
Advancing Global Collaboration in LDLT
全部分论坛
2025-10-17 星期五
Renji Hospital
09:00-15:30
Live Demonstration: Pediatric LDLT----Renji Hospital, Shanghai Jiao Tong University School of Medicine
主持：
何 康
【中国】
15:30-17:00
Council Meeting
15:30-16:30
Council Meeting-All iLDLTG Council Members
2025-10-18 星期六
Grand-ballroom II
08:00-08:10
大会开幕式
08:10-08:50
全体会议-主题演讲
08:50-10:25
Session 1(A) A Global Perspective of LDLT
10:20-10:25
Q&A (5 min)
10:25-11:30
Session 1(B) Technical Considerations in Minimally Invasive Donor Hepatectomy
10:55-11:10
How to establish a Robotic-assisted Donor Hepatectomy Program
11:25-11:30
Q&A (5 min)
11:30-12:50
Session 1(C) Transplant Oncology
11:30-11:45
Liver transplantation for hepatocellular carcinoma: surgical technique and innovations
12:15-12:30
Improving transplantibility for locally advanced HCC: the Hong Kong approach
12:45-12:50
Q&A (5 min)
12:50-14:00
午餐
14:00-15:30
Session 1(D) Technical Considerations in Recipient Surgery in LDLT
15:15-15:25
Q&A (10 min)
15:25-15:30
Coffee Break
15:30-17:30
Session 1(E) ILLS/iLDLTG Expert Discussion on MIDH
15:30-15:50
Group 1: Position and Port sites
钟成鹏
【中国】
Taizo Hibi
【日本】
Worakitti Lapisatepun
【泰国】
15:50-16:10
Group 2: Hilum dissection: portal vein, hepatic artery
Silvia Silva
【葡萄牙】
Thanh Le Van
【越南】
Sreejith Sreekumar
【印度】
Rajesh Rajalingam
【印度】
Taiga Wakabayashi
【日本】
16:10-16:30
Group 3: Parenchymal hepatic transection
Fabrizio di Benedetto
【意大利】
Yee Lee Cheah
【美国】
Jinsoo Rhu
【韩国】
Catherine Teh
【菲律宾】
Daniel Cherqui
【法国】
16:30-16:50
Group 4: Bile duct division
Yuta Abe
【日本】
罗 毅
【中国】
Seisuke Sakamoto
【日本】
Amar Gupta
【美国】
16:50-17:10
Group 5: Vascular division and graft out
Marco Vivarelli
【意大利】
Marco Spada
【意大利】
Juan Pablo Rocca
【美国】
Mukesh Kumar
【印度】
Fabrizio Di Francesco
【意大利】
Brian Goh Kim Poh
【新加坡】
17:10-17:30
Group 6: Anesthesia and Pain control
Justin Sangwook Ko
【美国】
David Victor
【美国】
Grand-ballroom III
14:00-15:20
Session 2(A) Transplant Pathology
14:00-14:15
Post-Liver Transplant Complications: Beyond Reiection and Recurrent Disease
14:15-14:30
Evolving Concepts in Liver Allograft Pathology: Insights from the Banff Liver Group
14:30-14:45
Liver allograft rejection in living donor liver transplant (LDLT) recipients
15:00-15:10
Q&A (10 min)
15:10-15:20
Coffee break
15:20-16:50
Session 2(B) Dealing with Marginal Donors in LT
15:40-16:00
Long-term outcomes of LT recipients using Hepatitis virus-positive donor liver
16:00-16:20
From Assessment to Donation: Hepatologist’s Insights on Preparing Living Liver Donors
16:40-16:50
Q&A (10 min)
Pearl room
09:00-10:20
Session 3(A) Advanced Technology in LT
09:30-09:45
Advances in Imaging Techniques in Liver to Achieve Precision Liver Surgery
09:45-10:00
The prediction of hcc recurrence after liver transplantation based on radiomics
10:00-10:15
Integrated, intelligent and international hospital establishment for higher quality clinical medical care
10:15-10:20
Q&A (5 min)
10:20-11:40
Session 3(B) Xenotransplant
11:35-11:40
Q&A (5 min)
11:40-12:45
Session 3(C) Expanding the Donor Pool in LT
11:40-11:55
Advancing Domino Liver Transplantation: Challenges, Strategies, and Future Perspectives
12:25-12:40
Waste-to-Resource Strategy in Liver Transplantation: Utilizing Discarded Partial Hepatectomy Grafts
12:40-12:45
Q&A (5 min)
12:45-13:15
午餐研讨会
主持：
朱志军
【中国】
12:45-13:15
Optimizing immunosuppression: a path to consistency, innovation, and improved outcomes
13:15-13:45
午餐研讨会
主持：
杨 扬
【中国】
13:15-13:45
Tacrolimus in focus: Striking the optimal balance through data-driven care and personalization
14:00-15:30
Session 3(D) Basic Science-Transplant Immunology
14:15-14:30
Donor Quality, Preservation, and Short-Term Outcomes in Liver Transplant: A Single-Cell and Spatial Analysis of Ischemia-Reperfusion Injury
14:30-14:45
EBV-reactive KIR+ CX3CR1+ CD8+ T cells mediate liver transplantation tolerance by targeting alloreactive CD4+ T cells
14:45-15:00
The Dual Regulatory Roles of Macrophages in Acute Allogeneic Organ Graft Rejection
15:15-15:25
Q&A (10 min)
15:30-17:57
Session 3(E) Oral Abstract Session (Young Investigator Award 2025)
15:30-15:37
Graft inflow modulation in living donor liver transplantation
15:37-15:44
Impact of the High Baseline Anti-A/B Antibody titer on the clinical outcomes in ABO-incompatible Living Donor Liver Transplantation
15:44-15:51
SEVEN-DAY CREATININE: A CRYSTAL BALL FOR KIDNEY FATE AFTER LIVER TRANSPLANT
15:51-15:58
Perioperative Management, Ethical Concerns, and Outcomes of Pediatric Domino Liver Transplants from Maple Syrup Urine Disease Donors
15:58-16:05
Evaluation Of Thrombocytopenia and Platelet Transfusion in Liver Transplant Recipients at a Quaternary Care Centre in South India
16:05-16:12
Peri-operative risk factors and outcomes in acute-on-chronic liver-failure (ACLF) patients undergoing living donor liver transplantation (LT)
16:12-16:19
Is a Functional Liver Remnant Volume Below 30% an Absolute Contraindication for Laparoscopic Living Liver Donors?
16:19-16:26
The Infection Puzzle in Liver Transplantation: Risk Factors, Outcomes and Clinical Strategy
16:26-16:33
Living Donor Liver Transplantation for Unresectable Colorectal Liver Metastasis – The University of Rochester Experience
16:33-16:40
Impact of Cold Ischemic Time on Rejection After Liver Transplantation: Is There a Safe Wondow?
16:40-16:47
Antioxidant Therapy for Prevention of Ischemia-Reperfusion Injury in Living Donor Liver Transplantation
16:47-16:54
Does GRWR Really Matters when Graft Weight is More than 650 gms in Living donor Liver Transplantation ????
16:54-17:01
Global Outcomes of Open versus Laparoscopic versus Robotic Donor Hepatectomy: A Prospective Study from the International LDLT Registry (LDLTregistry.org)
17:01-17:08
Renal Recovery Benefit of Living Donor Compared to Deceased Donor Liver Transplantation in High-MELD(≥35) Recipients: A Propensity Score-Matched Study
17:08-17:15
Clinical heterogeneity of refractory ascites after pediatric liver transplantation modulates allograft rejection risk
17:15-17:22
Mapping the Immunometabolic Landscape: Dual Axes of CCL3-Driven Macrophage Polarization and Succinate Signaling Drive Fibrosis in Pediatric Liver Transplant Recipients
17:22-17:29
Circadian Timing of Liver Transplantation Influences the Rejection Related Injury: A Retrospective Cohort Study
17:29-17:36
Mechanism of liver circFADS2 inhibiting rejection after liver transplantation in children
17:43-17:50
CRKP/MRSA Colonization Predicts Early Post-Liver Transplant Infection in Children: A Retrospective Matched Cohort Study
17:50-17:57
In Vivo Base Editing Gene Therapy for Heterozygous Familial Hypercholesterolemia with GalNAc-modified Lipid Nanoparticles
Yangtze River Hall
数智创新 肝愈氏界-肝癌肝移植高峰论坛
09:00-09:05
数智创新 肝愈氏界-肝癌肝移植高峰论坛
主持：
张建军
【中国】
09:05-10:00
第一篇章：数智创新
10:00-10:55
第二篇章：肝愈氏界
10:55-11:00
大会总结
主持：
张建军
【中国】
10:55-11:00
大会总结
郑树森
【中国】
11:00-11:30
午餐研讨会
主持：
蔡金贞
【中国】
“移路有约”肝移植技术及肝癌规范化论坛
12:00-12:10
“移路有约”肝移植技术及肝癌规范化论坛
12:00-12:15
开幕式
徐 骁
【中国】
12:10-13:25
Section 1 肝移植关键技术研讨
13:10-13:25
Endo Lab创新工坊
13:25-14:25
Section 2 肝癌规范化多学科建设
14:25-14:30
大会总结
主持：
张建军
【中国】
14:25-14:30
大会总结
徐 骁
【中国】
“植树中华”专题会
15:00-16:20
第一节
16:20-17:30
第二节
2025-10-19 星期日
Grand-ballroom II
08:30-09:40
Session 1 (F) Graft Matching in LDLT
09:30-09:40
Q&A (10 min)
09:40-10:50
Session 1(G) Paediatric LT -- Key Issues to consider
10:10-10:25
Indication of liver transplantation for metabolic liver disease in pediatric patients
10:25-10:40
Auxiliary Liver Transplantation for the Treatment of Acute Liver Failure in Children
10:40-10:50
Q&A (10 min)
10:50-11:30
iLDLTG GENERAL ASSEMBLY
11:30-13:00
午餐研讨会
主持：
张建军
【中国】
13:00-14:20
Session 1(H) Vanguard Project Presentation（10 min. presentations with 5 minutes Q&A）
14:25-15:55
Session 1(I) Video demonstration
主持：
TBD
【中国】
14:55-16:25
How to lmplant Modified Right Lobe Graft having V5,V8, and Inferior Right
15:55-16:05
闭幕式
Grand-ballroom III
08:30-09:40
Session 2(E) Immunological Considerations in Liver Transplantation
09:00-09:15
Donor-derived Regulatory DC infusion in Immune Tolerance: what we know
09:30-09:45
Q&A (10 min)
09:40-10:50
Session 2(F) Advances in Machine Perfusion in LT
10:40-10:50
Q&A (10 min)
11:30-13:00
午餐研讨会
13:00-14:25
Session 2(G) Peri-operative Considerations in Liver Transplantation
13:30-13:45
What is the timing of CBP after liver transplantation in critical liver failure recipients？
14:00-14:15
Diagnosis, Treatment, and Research of Severe Peri-operative Infections in Liver Transplantation
14:15-14:30
Q&A (10 min)
14:25-15:55
Session 2(H) Cell & Gene therapy -- From Bench to Bedside
14:25-14:45
From Lab to Clinic: Translating Bioengineered Liver Organoids for Precision Modeling and Regeneration
14:45-15:05
Progenitor Hepatocytes in Liver Disease: Therapeutic Potential and Translational Advances
15:45-15:55
Q&A (10 min)
Pearl room
肾移植专场
08:00-09:15
第一节
09:15-10:30
第二节
10:30-10:45
茶歇
10:45-11:45
第三节
11:45-12:45
第四节
12:45-14:00
午餐研讨会
主持：
戎瑞明
【中国】
移植捐献与管理
14:10-15:25
第一节
15:25-16:50
第二节
16:50-18:05
第三节
Yangtze River Hall
心肺胰腺小肠胰岛移植专场
08:00-09:30
一、胰岛暨再生胰岛移植
08:00-08:30
“Beyond Immunosuppression: Next-Generation Cell Therapies for T1DM（40 years anniversary of the invention of the Ricordi Chamber and Automated method）”
09:45-10:05
二、心肺胰腺小肠移植
11:25-13:00
三、胰岛移植+再生/异种胰岛
移植护理
14:00-14:10
主旨：聚焦·赋能·融合——构建高质量移植护理新格局
14:00-14:05
致辞
奚慧琴
【中国】
14:05-14:10
集体照
14:10-15:50
探索前沿护理模式，赋能移植护理发展
15:30-15:50
讨论
15:40-15:50
茶歇
15:50-17:20
深化专业能力与质量把控，引领移植护理专科建设
17:10-17:20
讨论